Search Results

A single-cell atlas of bone marrow B cells reveals defective central B-cell tolerance in immune thrombocytopenia

• Authors : Sheng, Z; Jiang, N; Gao, Y

• Source: BLOOD. 147(4):416-430

Record details

Development and Validation of a Novel Thrombosis Prediction Model for Adult Immune Thrombocytopenia (ITP-THROMBO).

• Authors : Yan, Huiling (AUTHOR); Hu, Xing (AUTHOR); Zhu, Lijun (AUTHOR)

• Source: Journal of Blood Medicine. Jan2026, Vol. 17, p1-15. 15p.

Record details

Platelet response to romiplostim amongst patients with newly diagnosed, persistent, and chronic immune thrombocytopenia in routine clinical practice in Denmark, Sweden, and Norway

• Authors : Christiansen, CF; Risbo, N; Ghanima, W

• Source: BRITISH JOURNAL OF HAEMATOLOGY. 205(4):1497-1507

Record details

Comparative analysis of primary immune thrombocytopenia and immune thrombocytopenia secondary to connective tissue diseases.

• Authors : Sun, Yingying¹ (AUTHOR); Yang, Jinyue¹ (AUTHOR); Li, Lijuan¹ (AUTHOR)

• Source: Hematology. Dec2025, Vol. 30 Issue 1, p1-10. 10p.

Record details

Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

• Source: A Randomized, Open-label Study To Compare The Efficacy And Safety Of Anti-CD38 Monoclonal Antibody Versus Rituximab in ITP Patients Who Failed or Relapsed After Glucocorticoid Therapy

Record details

Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

• Source: A Randomized, Open-label Study To Compare The Efficacy And Safety Of Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in ITP Patients Who Failed or Relapsed After Glucocorticoid

Record details

to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection

• Authors : Novartis; Qilu Hospital of Shandong University; The Second Affiliated Hospital of Kunming Medical University

• Source: A Multicenter Single-arm Study to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia in Chinese Patients With

Record details

Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)

• Authors : Beijing Children's Hospital; Tianjin People's Hospital; Henan Cancer Hospital

• Source: Clinical Characteristics, Prognosis and Prognostic Model of Pediatric Immune Thrombocytopenia: a Prospective, Multicenter, Observational

Record details

Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy (ORBIT)

• Source: Phase II Study of Orelabrutinib in Combination With Romiplostim in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received

Record details

Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)

• Source: A Randomized, Open-label Study To Compare The Efficacy And Safety Of Daratumumab Versus Rituximab in ITP Patients Who Failed or Relapsed After Glucocorticoid Therapy

Record details